Brain perfusion during rapid-eye-movement sleep successfully identifies amnestic mild cognitive impairment

Sleep Medicine
Pauline BrayetJacques Montplaisir

Abstract

Prodromal markers of Alzheimer's disease (AD) have been derived from wakefulness. However, brain perfusion during rapid-eye movement (REM) sleep could be a sensitive marker of amnestic mild cognitive impairment (aMCI), as activation of REM sleep relies more on the cholinergic system. Eight subjects with aMCI, and 16 controls, underwent two single-photon emission computed tomography (SPECT) scans with tracer injected during REM sleep then wakefulness. Perfusion in the anterior cingulate cortex was significantly decreased in aMCI cases compared to controls for both conditions. That defect was much larger and more severe in REM sleep (1795 voxels) compared to wakefulness (398 voxels), and extended to the middle cingulate cortex and the olfactory cortex. Hypoperfusion in the anterior cingulate cortex during REM sleep allowed better classification than hypoperfusion found in wakefulness (93.8 vs 81.3%). REM sleep imaging is a valuable tool with which to identify individuals at risk of developing AD.

Citations

Apr 18, 2020·Sleep Medicine Reviews·Angela L D'RozarioSharon L Naismith
Mar 11, 2019·Trends in Neurosciences·Anusha Mishra, Laura Lee Colgin
Aug 7, 2021·Nature and Science of Sleep·Xiangyi Gu, Junchao Zhu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Neuroimaging

Neuroimaging can help identify pathological hallmarks of Alzheimer's disease (AD). Here is the latest research on neuroimaging modalities, including magnetic resonance imaging and positron emission tomography, in AD.